The UK’s £10bn science and technology investment ecosystem stands at an inflection point.
Companies that a decade ago were yet to make their first sale have grown into fully commercial businesses with thousands of employees and customers around the world.
Venture capital, much of it provided by specialist funds with deep levels of expertise, has buoyed the market. The pipeline of research and entrepreneurial talent from Britain’s universities is the envy of the world and the policy environment is more supportive than it has ever been.
From this fertile landscape has emerged a generation of businesses with the potential to lead the world for decades to come. These companies, in fields such as artificial intelligence, quantum and advanced therapeutics, are primed for institutional capital to help them scale up and reach their global potential within the UK….
